AHSG and metabolic dysfunction-associated steatotic liver disease: Significantly higher levels of fetuin-A in patients with NAFLD were confirmed in a meta-analysis of 30 studies (Standardized Mean Difference—SMD = 0.83, 95% CI 0.59 to 1.07, Z-score = 6.82, p < 0.001) [73].